TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma-Reference-Cited by-同舟云学术

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

Published:2017-08-19 Issue:13 Volume:44 Page:2230-2238
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Albert Nathalie L.,Unterrainer M.,Fleischmann D. F.,Lindner S.,Vettermann F.,Brunegraf A.,Vomacka L.,Brendel M.,Wenter V.,Wetzel C.,Rupprecht R.,Tonn J.-C.,Belka C.,Bartenstein P.,Niyazi M.

Funder

Friedrich-Baur-Stiftung

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-017-3799-9/fulltext.html

Reference47 articles.

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. doi: 10.1016/S1470-2045(09)70025-7 .

2. Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:1100–8. doi: 10.1016/S1470-2045(14)70379-1 .

3. Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014;370:699–708. doi: 10.1056/NEJMoa1308573 .

4. Weller M, van den Bent M, Hopkins K, Tonn JC, Stupp R, Falini A, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014;15:e395–403. doi: 10.1016/S1470-2045(14)70011-7 .

5. Suchorska B, Albert NL, Tonn JC. Usefulness of PET imaging to guide treatment options in gliomas. Curr Treat Options Neurol. 2016;18:4. doi: 10.1007/s11940-015-0384-z .

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Medicine Imaging Techniques in Glioblastomas;Neurochemical Research;2024-09-05

2. Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease;Molecular Neurodegeneration;2024-09-05

3. Clinical Theranostics in Recurrent Gliomas: A Review;Cancers;2024-04-28

4. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-24

5. The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma;Biomedicines;2024-01-15